Clinically- versus serologically-identified varicella: A hidden infection burden. A ten-year follow-up from a randomized study in varicella-endemic countries

Varicella-zoster virus (VZV) infections cause a substantial disease burden, which is underestimated due to incomplete reporting data and lack of serological surveillance. In this post-hoc analysis of a randomized, Phase IIIb clinical trial (NCT00226499) with a ten-year follow-up period, we report an...

Full description

Bibliographic Details

Published in:	Human Vaccines & Immunotherapeutics
Main Authors:	Paul Gillard, Michael Povey, Stephane Carryn
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-10-01
Subjects:	vzv varicella burden of infection subclinical varicella vzv seroprevalence
Online Access:	http://dx.doi.org/10.1080/21645515.2021.1932217